Defective Drugs & Faulty Products
No Financial Recovery For You, No Legal FeeRequest Your Free Consultation
France Suspended Prescribing Actos
The ban on pioglitazone-containing medications was based on a study that showed an increased risk of bladder cancer in patients treated with pioglitazone for longer than a year. A pan-European review of pioglitazone safety began in March 2011.
In the United States, Takeda is funding a 10-year epidemiological study that began in 2002.
Our law firm holds drug manufacturers accountable for drugs' adverse effects, and strives to keep residents of North Carolina and Virginia updated when it hears of allegedly defective drugs. Contact Shapiro & Appleton if you or a loved one suffers injuries from Actos.